Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 3Suspended 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Refractory/Relapse Neuroblastoma 1Nasopharyngeal Carcinoma 1Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1

Interventions

Specimen Handling 480pembrolizumab 455Magnetic Resonance Spectroscopy 420Carboplatin 327Cyclophosphamide 314Cisplatin 271Biopsy 271Radiotherapy 244Paclitaxel 229Gemcitabine 227Bevacizumab 213Nivolumab 188fludarabine 185venetoclax 174Drug Therapy 170Blood Specimen Collection 158Dexamethasone 157Oxaliplatin 154Injections 152Capecitabine 151Fluorouracil 144Docetaxel 144Radiosurgery 137Standard of Care 135Rituximab 125Pemetrexed 117durvalumab 115Leucovorin 109atezolizumab 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Biological Products × 1 year × Clear all
NCT05608148 2025-11-18

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Kyushu University

Phase 1 Recruiting
61 enrolled
CNSOther solid neoplasm

Refractory/Relapse Neuroblastoma

NCT06348719 2025-09-15

ROBOT-ECO-GYN

Rennes University Hospital

Phase NA Recruiting
1,680 enrolled
Gynecologic

Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma

NCT05884983 2025-08-15

Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma

Zhongshan People's Hospital, Guangdong, China

Recruiting
12,000 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡